High Cd52 Mrna Expression Is An Adverse Prognostic Factor In Fludarabine-Refractory Cll Treated With Alemtuzumab On The Gcllsg Cll2h TrialMartin Sill,Christian Langer,Axel Benner,Thorsten Zenz,Andreas Bühler,Raymonde Busch,Peter Dreger,Ulrich Jäger,Michael Hallek,Hartmut Döhner,Stephan StilgenbauerBLOOD(2013)引用 3|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要